← Back to patent-cliff list
CAS 1000335-03-4
isopropyl (E)-2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxoprop-1-en-1-yl)phenoxy)-2-methylpropanoate
Codes: ELAF-005
Application context (from source-drug indications)
Sclerosing cholangitisElafibranorBiliary cirrhosisElafibranorNon-alcoholic steatohepatitisElafibranorRenal impairmentElafibranorKidney diseaseElafibranorHepatic function declineElafibranor
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Elafibranor | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
1-(4-(methylthio)phenyl)ethan-1-one→4-hydroxy-3,5-dimethylbenzaldehyde→(E)-3-(4-hydroxy-3,5-dimethylphenyl)-1-(4-(methylthio)phenyl)prop-2-en-1-one→isopropyl 2-bromo-2-methylpropanoate→isopropyl (E)-2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxoprop-1-en-1-yl)phenoxy)-2-methylpropanoate
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.